Metacrine, Inc.·4

Feb 12, 5:00 PM ET

Millican Trisha 4

4 · Metacrine, Inc. · Filed Feb 12, 2021

Insider Transaction Report

Form 4
Period: 2021-02-10
Millican Trisha
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-10+90,00090,000 total
    Exercise: $10.09Exp: 2031-02-09Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on the one year anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter until fully vested on February 10, 2025.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION